Adamis Pharmaceuticals Corporation Profile Avatar - Palmy Investing

Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candid…

Drug Manufacturers - Specialty & Generic
US, San Diego [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Adamis Pharmaceuticals Corporation mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of ADMP's Analysis
CIK: 887247 CUSIP: 00547W208 ISIN: US00547W2089 LEI: - UEI: -
Secondary Listings
ADMP has no secondary listings inside our databases.